Vortioxetine Hydrobromide

CHEMBL2107387 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

379.4 g/mol

LogP

—

Phase

4

A hydrobromide form of vortioxetine with the same therapeutic properties. This multimodal antidepressant is used to treat major depressive disorder and works by both blocking serotonin reuptake and modulating multiple serotonin receptor subtypes, which may offer benefits for mood and cognitive function.

Masse moléculaire

379,4000 g/mol

TPSA

40,60 Å²

Aires thérapeutiques

Major Depressive Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1

InChI

InChI=1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H

Molecular Formula

C18H23BrN2S

HBD / HBA

2 / 3

Liaisons Rotatives

3

Atomes Lourds

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A hydrobromide form of vortioxetine with the same therapeutic properties. This multimodal antidepressant is used to treat major depressive disorder and works by both blocking serotonin reuptake and modulating multiple serotonin receptor subtypes, which may offer benefits for mood and cognitive function.

Yes, Vortioxetine Hydrobromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107387. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 56843850. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Vortioxetine Hydrobromide sur PillFYI

Structure

Données Clés

Formule: C18H23BrN2S

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.